Clinical trials in India

被引：34

作者：

Maiti, Rituparna

Raghavendra, M.

机构：

[1] Prathima Inst Med Sci, Dept Pharmacol, Karimnagar 505417, Andhra Pradesh, India

[2] Banaras Hindu Univ, Inst Med Sci, Dept Pharmacol, Varanasi 221005, Uttar Pradesh, India

来源：

PHARMACOLOGICAL RESEARCH | 2007年 / 56卷 / 01期

关键词：

clinical trial; contract research; India;

D O I：

10.1016/j.phrs.2007.02.004

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

The concept of outsourcing for the development and global studies on new drugs has become widely accepted in the pharmaceutical industry due to its cost and uncertainty. India is going to be the most preferred location for contract pharma research and development due to its huge treatment naive population, human resources, technical skills, adoption/aniendinent/implementation of rules/laws by regulatory authorities, and changing economic environment. But still 'miles to go' to fulfill the pre-requisites to ensure India's success. In spite of all the pitfalls, the country is ambitious and optimist to attract multinational pharmaceutical companies to conduct their clinical trials in India. (C) 2007 Elsevier Ltd. All rights reserved.

引用

页码：1 / 10

页数：10